Literature DB >> 25772354

The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs.

Fiorella Ghisays1, Cynthia S Brace2, Shawn M Yackly1, Hyock Joo Kwon1, Kathryn F Mills2, Elena Kashentseva3, Igor P Dmitriev3, David T Curiel3, Shin-Ichiro Imai4, Tom Ellenberger5.   

Abstract

The NAD+-dependent protein deacetylase SIRT1 regulates energy metabolism, responses to stress, and aging by deacetylating many different proteins, including histones and transcription factors. The mechanisms controlling SIRT1 enzymatic activity are complex and incompletely characterized, yet essential for understanding how to develop therapeutics that target SIRT1. Here, we demonstrate that the N-terminal domain of SIRT1 (NTERM) can trans-activate deacetylation activity by physically interacting with endogenous SIRT1 and promoting its association with the deacetylation substrate NF-κB p65. Two motifs within the NTERM domain contribute to activation of SIRT1-dependent activities, and expression of one of these motifs in mice is sufficient to lower fasting glucose levels and improve glucose tolerance in a manner similar to overexpression of SIRT1. Our results provide insights into the regulation of SIRT1 activity and a rationale for pharmacological control of SIRT1-dependent activities.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2015        PMID: 25772354      PMCID: PMC4565781          DOI: 10.1016/j.celrep.2015.02.036

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  36 in total

Review 1.  Modern analytical ultracentrifugation in protein science: a tutorial review.

Authors:  Jacob Lebowitz; Marc S Lewis; Peter Schuck
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.

Authors:  Chuangui Wang; Lihong Chen; Xinghua Hou; Zhenyu Li; Neha Kabra; Yihong Ma; Shino Nemoto; Toren Finkel; Wei Gu; W Douglas Cress; Jiandong Chen
Journal:  Nat Cell Biol       Date:  2006-08-06       Impact factor: 28.824

3.  Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Authors:  W Fischle; E Verdin; W C Greene
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

4.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

5.  SIRT1 shows no substrate specificity in vitro.

Authors:  Gil Blander; Jerzy Olejnik; Edyta Krzymanska-Olejnik; Thomas McDonagh; Marcia Haigis; Michael B Yaffe; Leonard Guarente
Journal:  J Biol Chem       Date:  2005-01-06       Impact factor: 5.157

6.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

7.  The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells.

Authors:  Javier R Revollo; Andrew A Grimm; Shin-ichiro Imai
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

8.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

9.  Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.

Authors:  Joseph T Rodgers; Pere Puigserver
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

10.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.

Authors:  Dohoon Kim; Minh Dang Nguyen; Matthew M Dobbin; Andre Fischer; Farahnaz Sananbenesi; Joseph T Rodgers; Ivana Delalle; Joseph A Baur; Guangchao Sui; Sean M Armour; Pere Puigserver; David A Sinclair; Li-Huei Tsai
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

View more
  26 in total

1.  Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3.

Authors:  Sanghoon Kwon; Sunmi Seok; Peter Yau; Xiaoling Li; Byron Kemper; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

2.  Spatiotemporal gating of SIRT1 functions by O-GlcNAcylation is essential for liver metabolic switching and prevents hyperglycemia.

Authors:  Tandrika Chattopadhyay; Babukrishna Maniyadath; Hema P Bagul; Arindam Chakraborty; Namrata Shukla; Srikanth Budnar; Abinaya Rajendran; Arushi Shukla; Siddhesh S Kamat; Ullas Kolthur-Seetharam
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

3.  Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver.

Authors:  Sung E Choi; Sanghoon Kwon; Sunmi Seok; Zhen Xiao; Kwan-Woo Lee; Yup Kang; Xiaoling Li; Kosaku Shinoda; Shingo Kajimura; Byron Kemper; Jongsook Kim Kemper
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

4.  An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity.

Authors:  Troy C Krzysiak; Laurel Thomas; You-Jin Choi; Sylvain Auclair; Yiqi Qian; Shan Luan; Stephanie M Krasnow; Laura L Thomas; Leonardus M I Koharudin; Panayiotis V Benos; Daniel L Marks; Angela M Gronenborn; Gary Thomas
Journal:  Mol Cell       Date:  2018-11-08       Impact factor: 17.970

5.  Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1.

Authors:  Jian Fang; Alessandro Ianni; Christian Smolka; Olesya Vakhrusheva; Hendrik Nolte; Marcus Krüger; Astrid Wietelmann; Nicolas G Simonet; Juan M Adrian-Segarra; Alejandro Vaquero; Thomas Braun; Eva Bober
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

Review 6.  Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds.

Authors:  Michael S Bonkowski; David A Sinclair
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-24       Impact factor: 94.444

7.  Identification of a Tissue-Restricted Isoform of SIRT1 Defines a Regulatory Domain that Encodes Specificity.

Authors:  Shaunak Deota; Tandrika Chattopadhyay; Deepti Ramachandran; Eric Armstrong; Beatriz Camacho; Babukrishna Maniyadath; Amit Fulzele; Anne Gonzalez-de-Peredo; John M Denu; Ullas Kolthur-Seetharam
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

8.  Mechanism of Sirt1 NAD+-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation.

Authors:  Kelsey S Kalous; Sarah L Wynia-Smith; Michael D Olp; Brian C Smith
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

9.  Dietary Restriction and Epigenetics: Part I.

Authors:  Gavin Yong-Quan Ng; David Yang-Wei Fann; Dong-Gyu Jo; Christopher G Sobey; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-12

10.  CSAG2 is a cancer-specific activator of SIRT1.

Authors:  Xu Yang; Patrick Ryan Potts
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.